Am. J. Respir. Crit. Care Med., Volume 165, Number 2, January 2002, 273-276

Closed-Chest Microdialysis to Measure Antibiotic Penetration into Human Lung Tissue

HARALD HERKNER, MICHAEL ROLF MÜLLER, NICOLE KREISCHITZ, BERNHARD X. MAYER, MARTIN FROSSARD, CHRISTIAN JOUKHADAR, NIKOLAS KLEIN, EDITH LACKNER, and MARKUS MÜLLER

Department of Clinical Pharmacology, Division of Clinical Pharmacokinetics, Department of Emergency Medicine, and Department of Surgery, Division of Cardiothoracic Surgery, University of Vienna Medical School, Vienna, Austria

The majority of bacterial lung infections are localized to the interstitial space fluid, which is therefore an important target site for antimicrobial chemotherapy. Direct measurement of interstitial concentrations of antimicrobial agents in human lung tissue would allow for a more informed approach to appropriate dosing of antimicrobial agents, but until now this was beyond technical reach. In this exploratory pharmacokinetic study, we measured the time versus concentration profile of cefpirome after a single intravenous dose administration of 2 g in the lung interstitial fluid by flexible microdialysis catheters, which were implanted during lung surgery for pulmonary tumors in five patients. Cefpirome concentrations in lung interstitial fluid were 66% of corresponding plasma values within the first 240 min, and exceeded minimal inhibitory concentrations of most relevant bacteria. The experimental procedure was well tolerated by the patients and no adverse events were observed. The present study provides evidence for the first time that closed chest microdialysis of the human lung is a feasible and safe method to measure lung concentrations in patients in vivo. The present data also corroborate the use of cefpirome as a valuable agent in the treatment of lung infections with most extracellular bacteria.

This article has been cited by other articles:

				S. Schmidt, R. Banks, V. Kumar, K. H. Rand, and H. Derendorf Clinical Microdialysis in Skin and Soft Tissues: An Update J. Clin. Pharmacol., March 1, 2008; 48(3): 351 - 364. [Abstract] [Full Text] [PDF]

				M. A. Zeitlinger, B. M. Erovic, R. Sauermann, A. Georgopoulos, M. Muller, and C. Joukhadar Plasma concentrations might lead to overestimation of target site activity of piperacillin in patients with sepsis J. Antimicrob. Chemother., October 1, 2005; 56(4): 703 - 708. [Abstract] [Full Text] [PDF]

				R. Sauermann, G. Delle-Karth, C. Marsik, I. Steiner, M. Zeitlinger, B. X. Mayer-Helm, A. Georgopoulos, M. Muller, and C. Joukhadar Pharmacokinetics and Pharmacodynamics of Cefpirome in Subcutaneous Adipose Tissue of Septic Patients Antimicrob. Agents Chemother., February 1, 2005; 49(2): 650 - 655. [Abstract] [Full Text] [PDF]

				F. Tomaselli, A. Maier, V. Matzi, F. M. Smolle-Juttner, and P. Dittrich Penetration of Meropenem into Pneumonic Human Lung Tissue as Measured by In Vivo Microdialysis Antimicrob. Agents Chemother., June 1, 2004; 48(6): 2228 - 2232. [Abstract] [Full Text] [PDF]

				M. Muller, A. dela Pena, and H. Derendorf Issues in Pharmacokinetics and Pharmacodynamics of Anti-Infective Agents: Distribution in Tissue Antimicrob. Agents Chemother., May 1, 2004; 48(5): 1441 - 1453. [Full Text] [PDF]

				K. Yamazaki, S. Ogura, A. Ishizaka, T. Oh-hara, and M. Nishimura Bronchoscopic Microsampling Method for Measuring Drug Concentration in Epithelial Lining Fluid Am. J. Respir. Crit. Care Med., December 1, 2003; 168(11): 1304 - 1307. [Abstract] [Full Text] [PDF]

				M. J. Tobin Tuberculosis, Lung Infections, Interstitial Lung Disease, and Journalology in AJRCCM 2002 Am. J. Respir. Crit. Care Med., February 1, 2003; 167(3): 345 - 355. [Full Text] [PDF]

				M. Muller Science, medicine, and the future: Microdialysis BMJ, March 9, 2002; 324(7337): 588 - 591. [Full Text] [PDF]